Analytical and clinical evaluation of the enhanced liver fibrosis (ELF 2) panel

William Rosenberg(University of Southampton), Julie Parkes(University of Southampton), P.R. Roderick, Patrick A. Dillon(St. Louis Children's Hospital), Mahdi Vajdi(Isfahan University of Medical Sciences)
UCL Discovery (University College London)
June 1, 2007
Cited by 1

Related Papers

HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
|Science|2004|1.2k
Serum markers detect the presence of liver fibrosis: A cohort study
|Gastroenterology|2004|1.1k
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
|Gut|2012|792
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document
|Gut|2002|645
Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay
|Hepatology|2008|199